1. Burch HB, Wartofsky L. Graves' ophthalmopathy: current abdominal regarding pathogenesis and management. Endocr Rev. 1993; 14:747–93.
2. Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet. 1991; 338:25–8.
Article
3. Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy. Endocrinol Metab Clin North Am. 2000; 29:297–319.
Article
4. Bartalena L, Marocci C, Bogazzi F, et al. Glucocorticoid therapy of Graves' ophthalmopathy. Exp Clin Endocrinol. 1991; 97:320–7.
Article
5. Wiersinga WM. Immunosuppressive treatment of Graves' ophthalmopathy. Trends Endocrinol Metab. 1990; 1:377–81.
Article
6. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000; 21:168–99.
Article
7. McCord CD Jr. Current trends in orbital decompression. Ophthalmology. 1985; 92:21–33.
Article
8. Lyons CJ, Rootman J. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy. Ophthalmology. 1994; 101:223–30.
Article
9. Wenz R, Levine MR, Putterman A, et al. Extraocular muscle abdominal after orbital decompression for Graves' ophthalmopathy. Ophthal Plast Reconstr Surg. 1994; 10:34–41.
10. Hu WD, Annunziata CC, Chokthaweesak W, et al. Radiographic analysis of extraocular muscle volumetric changes in thyroid-abdominal orbitopathy following orbital decompression. Ophthal Plast Reconstr Surg. 2010; 26:1–6.
11. Alsuhaibani AH, Carter KD, Policeni B, Nerad JA. Effect of orbital bony decompression for Graves' orbitopathy on the volume of extraocular muscles. Br J Ophthalmol. 2011; 95:1255–8.
Article
12. Baldeschi L, Lupetti A, Vu P, et al. Reactivation of Graves' abdominal after rehabilitative orbital decompression. Ophthalmology. 2007; 114:1395–402.
13. Kalmann R, Mourits MP. Late recurrence of unilateral graves abdominal on the contralateral side. Am J Ophthalmol. 2002; 133:727–9.
14. Selva D, Chen C, King G. Late reactivation of thyroid orbitopathy. Clin Experiment Ophthalmol. 2004; 32:46–50.
Article
15. Nunery WR. Ophthalmic Graves' disease: a dual theory of pathogenesis. Ophthalmol Clin North Am. 1991; 4:73–87.
16. Nunery WR, Martin RT, Heinz GW, Gavin TJ. The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease. Ophthal Plast Reconstr Surg. 1993; 9:77–82.
Article
17. Nunery WR, Nunery CW, Martin RT, et al. The risk of diplopia abdominal orbital floor and medial wall decompression in subtypes of ophthalmic Graves' disease. Ophthal Plast Reconstr Surg. 1997; 13:153–60.
18. Park SJ, Kim YD. Two-wall orbital decompression for endocrine exophthalmos. J Korean Ophthalmol Soc. 1992; 33:907–13.
19. Bunting H, Creten O, Muhtaseb M, Shuttleworth G. Late reactivation of thyroid associated ophthalmopathy causing optic neuropathy. Postgrad Med J. 2008; 84:388–90.
Article
20. Chou PI, Feldon SE. Late onset dysthyroid optic neuropathy. Thyroid. 1994; 4:213–6.
Article
21. Dagi LR, Zoumalan CI, Konrad H, et al. Correlation between abdominal muscle size and motility restriction in thyroid eye disease. Ophthal Plast Reconstr Surg. 2011; 27:102–10.